Company Filing History:
1 out of 1 
1 out of 4 Years Active: 2012
Title: Esperanza Feijoo Blanco: Innovator in Peptide Research
Introduction
Esperanza Feijoo Blanco is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of biomedical research, particularly in the development of peptides that have the potential to inhibit the biological activity of transforming growth factor beta 1 (TGF-β1). Her work is crucial in addressing diseases associated with excessive TGF-β1 expression.
Latest Patents
Esperanza holds a patent for peptides with the capacity to bind to TGF-β1. These peptides are designed to inhibit the biological activity of TGF-β1 through direct binding, making them potential therapeutic agents for conditions such as liver fibrosis, pulmonary fibrosis, and corneal fibrosis.
Career Highlights
Throughout her career, Esperanza has worked with various organizations, including Proyecto Biomedicine Cima, S.L. and Digna Biotech, S.L. Her innovative research has positioned her as a key figure in the field of peptide technology and its applications in medicine.
Collaborations
Esperanza has collaborated with notable professionals in her field, including Javier Dotor Herrerías and Francisco Borrás Cuesta. These partnerships have further enhanced her research and development efforts.
Conclusion
Esperanza Feijoo Blanco is a trailblazer in peptide research, with a focus on developing innovative solutions for serious health conditions. Her contributions to science and medicine continue to pave the way for future advancements in therapeutic treatments.